AIEOP	AssociazioneItaliana di Ematologia e OncologiaPediatrica
AIM1	Absent in melanoma 1 protein
ALL	Acute lymphoblastic leukemia
AML	Acute myeloid leukemia
ANGPTL2	Angiopoietin-like 2
ARPP21	CAMP-regulated phosphoprotein 21
B-ALL	B-cell acute lymphoblastic leukemia
BCR::ABL1	BCR and ABL fusion gene
BCR::ABL1-like ALL	BCR and ABL fusion gene-like acute lymphoblastic leukemia
BFM	Berlin–Frankfurt–Münster
BIRC7	Baculoviral IAP repeat containing 7
BM	Bone marrow
BMF	Bcl2 modifying factor
BTG1	BTG-anti-proliferation factor 1
CD95	Cluster of differentiation 95
CDKN1A	Cyclin-dependent kinase inhibitor 1A
CDKN1B	Cyclin-dependent kinase inhibitor 1B
CLIC5	Chloride intracellular channel 5
CNAs	Copy number alteration
CNS1	CNS1 = patients with white blood cell count in cerebrospinal fluid < 5 and having no blasts in the cerebrospinal fluid
DLBCL	Diffuse large B-cell lymphoma
EBF1	EBF transcription factor 1
EFS	Event-free survival
ETS	Erythroblast transformation specific
ETV6	ETS variant transcription factor 6
ETV6::RUNX1	ETS variant transcription factor 6 and RUNX family transcription factor 1 fusion gene
ETV6::RUNX1-like ALL	ETS variant transcription factor 6 and RUNX family transcription factor 1 fusion gene-like acute lymphoblastic leukemia
ETV6::RUNX1+	ETV6::RUNX1-positive
ETV6::RUNX1−	ETV6::RUNX1-negative
FISH	Fluorescence in situ hybridization (FISH)
FLT3	Fms-related receptor tyrosine kinase 3
FOXO3A	Forkheadbox O3
FPD/AML	familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML)
FRALLE 93	French group for childhood ALL 93 trial (FRALLE 93
GD-ALL-2008	Guangdong Children’s Leukemia Group-ALL-2008
GDP	Guanosine diphosphate
GIPFEL	Genomic inverse PCR for exploration of ligated breakpoints
GTP	Bound and inactive guanosine diphosphate
HLH	Helix loop helix
HRAS	HRasproto-oncogene, GTPase
HSCs	Hematopoietic stem cells
iAMP21	Intrachromosomal amplification of chromosome 21
IGF2BP	Insulin-like growth factor 2 mRNA-binding protein
IGF2BP1	Insulin-like growth factor 2 MRNA-Binding Protein 1
IGF2BP2	Insulin-like growth factor 2 MRNA-Binding Protein 2
IGF2BP3	Insulin-like growth factor 2 MRNA-Binding Protein 3
IGH::IL3	Immunoglobulin heavy locus and interleukin 3 fusion gene
IL7R	Interleukin 7 receptor
KMT2A	lysine methyltransferase 2A
KRAS	KRAS proto-oncogene, GTPase
L-ASP	L-asparaginase
MDS	Myelodysplastic syndrome
MLL-r	mixed-lineage leukemia gene rearrangement
MLPA	Multiplex ligation probe-dependent amplification
MRD	Minimal residual disease
NF1	Neurofibromin 1
NGS	Next-generation sequencing
NOPHO	Nordic Society of Pediatric Hematology and Oncology
NR3C1	Nuclear receptor subfamily 3 group C member 1
NRAS	NRAS proto-oncogene, GTPase
OS	Overall survival
PAX5	Paired box 5
PTPN11	Protein tyrosine phosphatase non-receptor type 11
PTPN11	Protein tyrosine phosphatase non-receptor type 11
RAGs	Recombination-activating genes
RAS	Protein family include
RHD	DNA-binding Runt-domain
RT-PCR	Reverse transcriptase-polymerase chain reaction
RUNX1	RUNX family transcription factor 1
SPI-B	Spi-B transcription factor
SYK	Spleen tyrosine kinase
T-ALL	T-cell acute lymphoblastic leukemia
TCF3::HLF	Transcription factor 3 and HLF transcription factor fusion gene
TCF3::PBX1	Transcription factor 3 and PBX homeobox 1
WBC	White blood cell
WBP1L	WW domain-binding protein 1-like
WGS/WES	Whole genome/whole exome sequencing
WHO-HAEM5	5th edition of the World Health Organization Classification of HaematolymphoidTumours
ZFP423	Zinc finger protein 423